New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June 2...
A May 2024 cohort study reveals prenatal PFAS exposure reduces maternal beta cell function by 15-20%, increasing diabetes risk. EU proposals and NIH funding highlight urgent public health responses. R...